These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 10698338

  • 1. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F, Muñoz E, Vidarte L, Pastor C.
    Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
    [Abstract] [Full Text] [Related]

  • 2. The C(H)1 domain of IgG is not essential for C3 covalent binding: importance of the other constant domains as targets for C3.
    Muñoz E, Vidarte L, Casado MT, Pastor C, Vivanco F.
    Int Immunol; 1998 Feb; 10(2):97-106. PubMed ID: 9580208
    [Abstract] [Full Text] [Related]

  • 3. Serine 132 is the C3 covalent attachment point on the CH1 domain of human IgG1.
    Vidarte L, Pastor C, Mas S, Blázquez AB, de los Rios V, Guerrero R, Vivanco F.
    J Biol Chem; 2001 Oct 12; 276(41):38217-23. PubMed ID: 11447230
    [Abstract] [Full Text] [Related]

  • 4. A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes.
    Muñoz E, Vidarte L, Pastor C, Casado M, Vivanco F.
    Eur J Immunol; 1998 Aug 12; 28(8):2591-7. PubMed ID: 9710236
    [Abstract] [Full Text] [Related]

  • 5. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
    Barrio E, Antón LC, Marqués G, Sánchez A, Vivanco F.
    Eur J Immunol; 1991 Feb 12; 21(2):343-9. PubMed ID: 1999223
    [Abstract] [Full Text] [Related]

  • 6. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
    Edberg JC, Tosic L, Wright EL, Sutherland WM, Taylor RP.
    J Immunol; 1988 Dec 15; 141(12):4258-65. PubMed ID: 3198918
    [Abstract] [Full Text] [Related]

  • 7. How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.
    Lutz HU.
    Adv Exp Med Biol; 2012 Dec 15; 750():186-96. PubMed ID: 22903675
    [Abstract] [Full Text] [Related]

  • 8. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y, Tamura N, Fujita T.
    J Immunol; 1984 May 15; 132(5):2531-7. PubMed ID: 6232320
    [Abstract] [Full Text] [Related]

  • 9. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC, Ruiz S, Barrio E, Marqués G, Sánchez A, Vivanco F.
    Eur J Immunol; 1994 Mar 15; 24(3):599-604. PubMed ID: 8125130
    [Abstract] [Full Text] [Related]

  • 10. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ, Reid KB.
    Biochem J; 1981 May 01; 195(2):471-80. PubMed ID: 7316962
    [Abstract] [Full Text] [Related]

  • 11. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN, Dixon FJ, Bokisch VA.
    J Exp Med; 1974 Oct 01; 140(4):877-94. PubMed ID: 4139225
    [Abstract] [Full Text] [Related]

  • 12. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC, Alcolea JM, Sánchez-Corral P, Marqués G, Sánchez A, Vivanco F.
    Biochem J; 1989 Feb 01; 257(3):831-8. PubMed ID: 2784671
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT, Lambris JD, Tsokos GC, Burger R, Bitter-Suermann D, Tamerius JD, Dixon FJ, Theofilopoulos AN.
    J Clin Invest; 1985 Oct 01; 76(4):1418-26. PubMed ID: 2932466
    [Abstract] [Full Text] [Related]

  • 14. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
    Baatrup G, Svehag SE, Jensenius JC.
    Scand J Immunol; 1986 Apr 01; 23(4):397-406. PubMed ID: 3486458
    [Abstract] [Full Text] [Related]

  • 15. Breakdown of C3 covalently bound to F(ab')2 immune complexes after complement activation by the alternative pathway.
    Antón LC, Alcolea JM, Marqués G, Sánchez-Corral P, Vivanco F.
    Complement; 1986 Apr 01; 3(2):53-62. PubMed ID: 3769463
    [Abstract] [Full Text] [Related]

  • 16. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.
    Jelezarova E, Luginbuehl A, Lutz HU.
    J Biol Chem; 2003 Dec 19; 278(51):51806-12. PubMed ID: 14527961
    [Abstract] [Full Text] [Related]

  • 17. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL, Mikus LK.
    J Exp Med; 1985 Jun 01; 161(6):1414-31. PubMed ID: 2409200
    [Abstract] [Full Text] [Related]

  • 18. Interaction of C3 and C3b with immunoglobulin G.
    Kulics J, Rajnavölgyi E, Füst G, Gergely J.
    Mol Immunol; 1983 Aug 01; 20(8):805-10. PubMed ID: 6621540
    [Abstract] [Full Text] [Related]

  • 19. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
    Kávai M, Rasmussen JM, Baatrup G, Zsindely A, Svehag SE.
    Scand J Immunol; 1988 Jul 01; 28(1):123-8. PubMed ID: 2969612
    [Abstract] [Full Text] [Related]

  • 20. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation.
    Sahu A, Pangburn MK.
    J Biol Chem; 1994 Nov 18; 269(46):28997-9002. PubMed ID: 7961863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.